The effect of zoledronic acid on aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole: The Z-FAST study 5-year final follow-up. - Brufsky,A.; Harker,G.; Beck,J.T. (Cancer Res, 2009)